Trial intelligence / Profile preview

Rectal versus intramuscular diclofenac sodium for post-caesarean pain relief

PACTR202210622254726Phase 3Not yet recruiting

Sponsor
DR UGWU PAULINUS CHUKWUEMEKA
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of diclofenac in postoperative pain (2 arms), sponsored by DR UGWU PAULINUS CHUKWUEMEKA. Primary endpoint: Effectiveness of pain relief. Planned start Oct 2022; status: not yet recruiting.

02

Drugs

diclofenac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202210622254726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202210622254726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call